28 December 2019 in Polymers for Advanced Technologies
19 October 2022 in Optical Fiber Technology
21 May 2025 in Advanced Science
The integration of 2D‐materials and optoelectronic devices has attracted great attention for advanced applications. We propose the first perovskite/graphene heterostructure‐based FET biosensor with uniquely biotunable ternary logic gating functionality. The biosensor integrates a lateral perovskite‐on‐graphene heterostructure phototransistor with a vertical bio‐nano‐photonic filter, with a decoupled construction inset. In the phototransistor, photoactive perovskite quantum dots (PQDs) serve as sensitizers to absorb light while a high mobility single‐layer graphene (SLG) acts as an expressway for carrier transport. In the bio‐nano‐photonic filter, a localized surface plasmon resonance (LSPR) is induced by gold nanoparticles (AuNPs) in conjunction with antigen‐antibody binding, tuning the delivery of light passing through the filter and facilitating biotunable functionality with ternary modes. The biosensor is set up to detect human interleukin‐6 (IL6) in order to determine and achieve ultrahigh sensitivity with a limit of detection (LOD) of 0.9 fg mL −1 (43 aM), which is 4 orders of magnitude greater than graphene‐FET biosensors. This ultrahigh sensitivity is achieved due to the synergistic effect of PQDs/SLG heterostructure, exhibiting superior electrical, optical, and physicochemical properties, consequently providing significantly high performance of the biosensor in terms of label‐free, ultrahigh sensitivity (attomolar level), rapid responsivity (5 min), excellent stability, and selectivity. This heterostructure‐based biotunable configuration could open a new avenue for 2D materials in the realm of next‐generation bio‐nano‐photonic platforms for applications in healthcare, early diagnosis, and rapid detection.
18 August 2025 in ACS Applied Nano Materials
Accurate and noninvasive detection of cancer cells is critical for advancing early stage cancer diagnostics and monitoring tumor progression. While manual enumeration methods, such as hemocytometry, remain in use, they suffer from limited sensitivity and scalability. In this article, we report the first feasibility study demonstrating a graphene oxide (GO)-functionalized long-period fiber grating (LPG) sensor for the label-free detection of MCF-7 human breast cancer cell density via secreted cellular byproducts. The sensing mechanism is based on refractive index (RI) modulation in the culture medium, where the GO overlay serves as a functional interface to enhance light–matter interaction and mode coupling between the LPG device and the external medium. GO nanocoatings were deposited on the device surface via an in situ layer-by-layer (i-LbL) assembly method and characterized using scanning electron microscopy (SEM), atomic force microscopy (AFM), and Raman spectroscopy. Furthermore, by precisely controlling the thickness of the GO nanocoating, we experimentally investigated the impact of the GO thickness on the optical properties, revealing distinct thickness-dependent behavior. Resonance changes correlated clearly with metabolite accumulation, thus enabling indirect detection of cancer cell density. The GO-LPG sensor demonstrated detection of MCF-7 cell densities ranging from 0 to 1 × 105 cells/mL, achieving ultrahigh sensitivity with a limit of detection (LOD) as low as 270 cells/mL. This GO-functionalized fiber optic configuration offers significant potential as a real-time, label-free, and noninvasive bionanophotonic platform for cancer diagnostics and metabolic sensing in complex biological environments.
1 September 2007 in Optics Communications
3 April 2010 in Microfluidics and Nanofluidics